Generated by Meeveem AI
"Leading biomarker and bioanalytical CRO advancing therapeutic pipelines through precision science"
Synexa Life Sciences is a biomarker and bioanalytical contract research organisation developing, validating and delivering custom assays. With over 200 staff including 120+ scientists across laboratories in Manchester, Turku and Cape Town, the company supports pharmaceutical, biotech and academic partners from discovery through regulatory submission. Services span biomarker identification, clinical bioanalysis, flow cytometry, mass spectrometry and immunoassays. The company translates biological hypotheses into regulatory compliant data. By integrating into client teams, Synexa reduces trial risk, validates therapeutic biology in disease models, and delivers mechanistic data across pharmacokinetics, immunogenicity and biomarker endpoints.
210
Team Members
2003
Founded
Contract Research
Sector
On-Site
Work Environment
A world where every therapeutic innovation reaches patients faster through precise, reliable biomarker science that eliminates uncertainty and accelerates drug development timelines.
Synexa Life Sciences empowers pharmaceutical and biotech partners to advance life-changing therapies by delivering specialist biomarker and bioanalytical services that translate complex biology into actionable, regulatory compliant data.